A Single Center Study to Evaluate the Penetration of RO7033877 Into the Lung in Healthy Volunteers

Trial Profile

A Single Center Study to Evaluate the Penetration of RO7033877 Into the Lung in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Jun 2016

At a glance

  • Drugs RO 7033877 (Primary)
  • Indications Unspecified
  • Focus Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy
    • 14 Oct 2014 Status changed from recruiting to completed, as reported by ClinicalTrials.gov record.
    • 07 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top